Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, Compd. With Piperazine (1:1)
2. Genoral
3. Harmogen
4. Harmonet
5. Ogen
6. Ortho-est
7. Piperazine Estrone Sulfate
1. 7280-37-7
2. Piperazine Estrone Sulfate
3. Ogen
4. Harmogen
5. Ortho-est
6. Estrone Sulfate Piperazine Salt
7. Sulestrex Piperazine
8. Piperazine Estrone Sulphate
9. Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, Compd. With Piperazine (1:1)
10. Svi38uy019
11. Piperazine Estronesulfate
12. Nsc-758912
13. Estrone Hydrogen Sulfate Compound With Piperazine (1:1)
14. Sulestrex
15. Unii-svi38uy019
16. Piperazine (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl Sulfate
17. Ogen 5
18. Pipestrone
19. Estropipate [usp:inn:ban]
20. Ogen 2.5
21. Ogen .625
22. Ogen 1.25
23. Einecs 230-696-3
24. Estropipate (usp)
25. Ogen (tn)
26. Piperazineestronesulfate
27. Ncgc00016682-02
28. Dsstox_cid_3005
29. Cas-7280-37-7
30. Estropipate [vandf]
31. Piperazine Oestrone Sulphate
32. Conjugated Estrogens: Piperazine Estrone Sulfate
33. Dsstox_rid_76828
34. Estropipate [mart.]
35. Dsstox_gsid_23005
36. Schembl21577
37. Estropipate [usp-rs]
38. Estropipate [who-dd]
39. Mls002153957
40. Chebi:4873
41. Chembl1200980
42. Dtxsid3023005
43. Piperazine, Compd. With Estrone Hydrogen Sulfate (1:1)
44. Estrone, Hydrogen Sulfate, Compd. With Piperazine (1:1)
45. Estropipate [orange Book]
46. Hms1570i17
47. Hms2097i17
48. Hms2232o19
49. Hms3714i17
50. Estropipate [usp Monograph]
51. Bcp05424
52. Hy-b1361
53. Tox21_113350
54. S5288
55. Akos024457702
56. Estra-1,3,5(10)-trien-17-one 3-sulphate, Compound With Piperazine (1:1)
57. Piperazine, Compd. With 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1)
58. Bcp9000662
59. Ccg-220688
60. Cs-4818
61. Estropipate, >=98% (hplc), Powder
62. Nsc 758912
63. [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Hydrogen Sulfate,piperazine
64. Smr001233296
65. Am20080957
66. Estrone Sulfate Piperazine Salt [mi]
67. D00948
68. 280e377
69. A837628
70. Sr-01000000235
71. Q5401860
72. Sr-01000000235-5
73. Estrone Hydrogen Sulphate Compound With Piperazine (1:1)
74. Estropipate, United States Pharmacopeia (usp) Reference Standard
75. 17-oxoestra-1,3,5(10)-trien-3-yl Hydrogen Sulfate - Piperazine (1:1)
76. [(8r,9s,13s,14s)-13-methyl-17-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Hydrogen Sulfate; Piperazine
77. [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Hydrogen Sulfate;piperazine
78. Piperazine; Sulfuric Acid [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Ester
Molecular Weight | 436.6 g/mol |
---|---|
Molecular Formula | C22H32N2O5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 436.20319330 g/mol |
Monoisotopic Mass | 436.20319330 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 650 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 10 | |
---|---|
Drug Name | Estropipate |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1.5mg; 3mg; 0.75mg |
Market Status | Prescription |
Company | Watson Labs; Mylan; Barr |
2 of 10 | |
---|---|
Drug Name | Ogen .625 |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.75mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
3 of 10 | |
---|---|
Drug Name | Ogen 1.25 |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1.5mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
4 of 10 | |
---|---|
Drug Name | Ogen 2.5 |
PubMed Health | Estropipate |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent, Musculoskeletal Agent |
Drug Label | Estropipate (formerly piperazine estrone sulfate), is a natural estrogenic substance prepared from purified crystalline estrone, solubilized as the sulfate and stabilized with piperazine. It is appreciably soluble in water and has almost no odor or t... |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 3mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
5 of 10 | |
---|---|
Drug Name | Ogen 5 |
PubMed Health | Estrogen |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 6mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
6 of 10 | |
---|---|
Drug Name | Estropipate |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1.5mg; 3mg; 0.75mg |
Market Status | Prescription |
Company | Watson Labs; Mylan; Barr |
7 of 10 | |
---|---|
Drug Name | Ogen .625 |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.75mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
8 of 10 | |
---|---|
Drug Name | Ogen 1.25 |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 1.5mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
9 of 10 | |
---|---|
Drug Name | Ogen 2.5 |
PubMed Health | Estropipate |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent, Musculoskeletal Agent |
Drug Label | Estropipate (formerly piperazine estrone sulfate), is a natural estrogenic substance prepared from purified crystalline estrone, solubilized as the sulfate and stabilized with piperazine. It is appreciably soluble in water and has almost no odor or t... |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 3mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
10 of 10 | |
---|---|
Drug Name | Ogen 5 |
PubMed Health | Estrogen |
Active Ingredient | Estropipate |
Dosage Form | Tablet |
Route | Oral |
Strength | 6mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
Contraceptive Agents, Hormonal
Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?